DeepMed Research

TC-6987

Generic Name: TC-6987

Drug Type: Small Molecule

Chemical Formula: C_₂₀H_₂₁F_₂N_₃O

CAS Number: 1196701-27-5

Unique Ingredient Identifier: Q2U4R164OG

Background: TC-6987 is under investigation in clinical trial NCT01296087 (TC-6987 for the Treatment of Mild to Moderate Asthma).

Clinical Trials

TC-6987 for the Treatment of Mild to Moderate Asthma

Phase 2

Completed

Conditions: Asthma

Interventions: Drug: TC-6987
Drug: Placebo

First Posted Date: 2011-02-15

Last Posted Date: 2013-09-13

Lead Sponsor: Targacept Inc.

Target Recruit Count: 203

Registration Number: NCT01296087

Locations: 🇺🇸
Sarasota Clinical Research, Sarasota, Florida, United States
🇺🇸
Allergy & Asthma Research of New Jersey, Inc., Philadelphia, Pennsylvania, United States
🇺🇸
Pioneer Research Solutions, Houston, Texas, United States

and more 18 locations

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

Phase 2

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: TC-6987
Drug: Placebo

First Posted Date: 2011-02-10

Last Posted Date: 2013-09-13

Lead Sponsor: Targacept Inc.

Target Recruit Count: 440

Registration Number: NCT01293669

Locations: 🇺🇸
PMG Research of WS, Winston-Salem, North Carolina, United States
🇺🇸
Clopton Clinic, Jonesboro, Arkansas, United States
🇺🇸
Cedar Crosse Research Center, Chicago, Illinois, United States

and more 15 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy